Kousaku Okamura

Title: Kousaku Okamura: Innovator in Antimicrobial Cephalosporins

Introduction

Kousaku Okamura is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin derivatives. With a total of 4 patents to his name, Okamura's work has had a considerable impact on antimicrobial treatments.

Latest Patents

His latest patents include innovative compounds such as N-acylamino-α-arylacetamido cephalosporins. This cephalosporin derivative is characterized by a formula where A represents a mono- or polycyclic heteroaromatic ring containing at least one nitrogen atom. The phenyl group R is substituted with various functional groups, including amino, hydroxy, ureido, and hydroxymethyl groups. Additionally, the compound features an --OCOCH₃ group or an --S-Het group, where Het is a heterocyclic ring. These compounds are designed to be non-toxic and pharmaceutically acceptable, making them useful as antimicrobial agents.

Career Highlights

Kousaku Okamura is currently associated with Sumitomo Chemical Company, Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the efficacy of antimicrobial agents, contributing to advancements in medical treatments.

Collaborations

Okamura has collaborated with esteemed colleagues such as Takenari Nakagome and Toshiaki Komatsu. Their joint efforts have furthered research and development in the field of cephalosporins.

Conclusion

Kousaku Okamura's contributions to the field of pharmaceuticals, particularly in the development of antimicrobial cephalosporins, highlight his role as a significant inventor. His innovative work continues to influence the medical community and improve treatment options for various infections.